WeVote
Log In

Bill

Bill

AB 228

Pupil health: epinephrine delivery systems.

2025-2026 Regular Session Introduced by Dawn Addis and 3 co-sponsors

AB 228 mandates California schools stock epinephrine auto-injectors and train staff to administer them during allergic emergencies, potentially preventing anaphylaxis deaths among students.

In committee: Hearing postponed by committee.
#pupilhealth #epinephrinedeliverysystems
0
WeVote Research Nonpartisan
Bill Summary · AB 228

Legislative bill overview

AB 228 requires California schools to maintain epinephrine auto-injectors (EpiPens) on campus and establishes protocols for their use in emergency situations involving allergic reactions. The bill aims to ensure rapid access to life-saving medication during anaphylaxis events, which can be fatal if untreated.

Why is this important

Severe allergic reactions can progress rapidly and fatally within minutes, making immediate access to epinephrine critical in school settings where children spend significant time. Currently, schools vary widely in epinephrine availability and staff training, leaving some students at risk during emergencies. Standardizing this requirement across California schools could prevent deaths and serious complications from preventable anaphylactic shock.

Potential points of contention

  • Cost and funding: Schools must purchase and maintain epinephrine supplies; unclear whether the state will provide funding or place the burden on district budgets already facing constraints
  • Liability and training: Questions remain about staff liability if epinephrine is administered incorrectly, and whether adequate training requirements are specified for school personnel
  • Access and equity: Implementation standards may vary by district wealth and resources, potentially creating disparities in response capabilities across socioeconomic communities

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.